Your institution may have access to this item. Find your institution then sign in to continue.
Title
The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.
Authors
Sarris, J; Kavanagh, D J; Byrne, G; Bone, K M; Adams, J; Deed, G
Abstract
Piper methysticum (Kava) has been withdrawn in European, British, and Canadian markets due to concerns over hepatotoxic reactions. The WHO recently recommended research into "aqueous" extracts of Kava.